CAS 2226894-58-0 PSMA-1007

Send Inquiry
CAS 2226894-58-0 PSMA-1007
Details
CAS: 2226894-58-0
Core structure: Glu-urea-Lys high-affinity PSMA binding scaffold with aromatic side chain optimized receptor affinity, small molecule peptide-like imaging ligand
We also provide specifications from crude to 99% purity, please contact us for details!


Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Targeting Imaging Ligand / PSMA Prostate Cancer PET Imaging Precursor
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 2226894-58-0 psma-1007 in China, also supports custom service. Welcome to wholesale bulk high quality cas 2226894-58-0 psma-1007 from our factory. Contact us for more details.

 

Product name CAS:2226894‑58‑0 PSMA‑1007
Description PSMA‑1007 is a new‑generation high‑affinity PSMA‑targeted small molecule peptide‑like ligand. It specifically binds to PSMA protein highly expressed on prostate cancer cell surfaces via the urea bond scaffold. It can be labeled with radionuclides for PET imaging of prostate cancer and metastases, and also applied in PSMA pathway research and targeted drug structure‑activity relationship analysis.
Peptide purity (HPLC, %) 95%/98%/99%
Theoretical molecular weight ~540 Da
Structure type Glu‑urea‑Lys peptide‑like small molecule with aromatic side chain modification
   

 

Products Description

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Structure Type Target Affinity
PSMA-1007 PSMA-1007; Prostate-specific membrane antigen ligand; PSMA PET imaging precursor; CAS 2226894-58-0 High-affinity PSMA targeting,Prostate cancer imaging,Metastasis detection,Radionuclide imaging precursor,SAR research,Urologic oncology study Glu-urea-Lys core scaffold with aromatic hydrophobic side chain optimized binding C₂₈H₃₃N₃O₈ (theoretical) 539.23 540.58 Peptide-like small molecule urea derivative Nanomolar high affinity

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-P100701 white powder Store at -20℃, sealed, dry & protected from light, aliquoted; avoid high temperature and humidity Solid powder stable for 2 years at 2-8℃ sealed and dry; prepare solutions freshly before labeling Stable for 72 h at 4℃; stable for 1 month at -20℃ in aliquots. **Limited water solubility, small amount of DMSO or acetonitrile required for solubilization**. Aromatic side chains prone to oxidative degradation under light. Urea bond structure stable to acid/base Stable for 3 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-P100701 High-affinity PSMA targeting ligand that specifically binds prostate cancer cells for tumor imaging and targeting research PSMA-1007 is a new-generation PSMA small molecule ligand optimized based on glutamate-urea-lysine scaffold. It mimics peptide bond structure via urea bond, and binds with high affinity and specificity to the enzymatic active site of prostate-specific membrane antigen (PSMA) highly expressed on prostate cancer cell membranes, sterically blocking its hydrolase function. Compared with first-generation PSMA ligands, aromatic side chain modifications further improve receptor affinity and in vivo tumor targeting, with lower non-target tissue background and higher imaging contrast. This molecule can be labeled with radionuclides for high-sensitivity PET imaging of primary prostate cancer, lymph node metastasis and bone metastasis, and also serves as a lead compound for structure-activity relationship screening of PSMA-targeted therapeutic drugs, receptor binding kinetics analysis and tumor targeted delivery mechanism research. Prostate cancer research,Nuclear medicine PET imaging,Tumor metastasis study,PSMA pathway study,Targeted drug development,Urologic oncology research Prostate-Specific Membrane Antigen (PSMA); PSMA enzymatic active site binding; Tumor targeted enrichment and imaging pathway

Hot Tags: cas 2226894-58-0 psma-1007, China cas 2226894-58-0 psma-1007 manufacturers, suppliers, factory, 121062-08-6, 1415456-99-3, 2381089-83-2, 910463-68-2, CAS 1415456 99 3, Semaglutide

Send Inquiry